Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2012 07:30 ET | Source: Zogenix

Zogenix and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology

SAN DIEGO and COLUMBUS, Ohio, March 29, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous...
March 08, 2012 16:08 ET | Source: Zogenix

Zogenix Reports Fourth Quarter and Full Year 2011 Financial Results

Provides 2012 Financial Guidance Conference Call and Webcast Today, March 8th, at 4:30 p.m. ET SUMAVEL® DosePro® (sumatriptan injection) Highlights Increased total prescriptions...
February 27, 2012 16:05 ET | Source: Zogenix

Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2011 Financial Results

SAN DIEGO, Feb. 27, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
February 10, 2012 07:30 ET | Source: Zogenix

Zogenix to Present at Leerink Swann 2012 Global Healthcare Conference

SAN DIEGO, Feb. 10, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
January 25, 2012 07:30 ET | Source: Zogenix

Zogenix and Battelle to Collaborate on Advanced Drug Delivery Technology

SAN DIEGO and COLUMBUS, Ohio, Jan. 25, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous...
December 21, 2011 07:35 ET | Source: Zogenix

Zogenix Reviews Positive Sales Trends and 2012 Commercial Initiatives for SUMAVEL(R) DosePro(R)

Evaluating New Co-Promotion Opportunities to Supplement Zogenix U.S. Sales Team Zogenix to Host Conference Call Today at 9:00 am ET SAN DIEGO, Dec. 21, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc....
December 21, 2011 07:30 ET | Source: Zogenix

Zogenix and Astellas Agree to End Co-Promotion for SUMAVEL(R) DosePro(R) Effective March 31, 2012

SAN DIEGO and Deerfield, Ill., Dec. 21, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous...
December 20, 2011 07:30 ET | Source: Zogenix

Zogenix Completes Zohydro(TM) Pre-NDA Meetings With FDA

SAN DIEGO, Dec. 20, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
November 21, 2011 07:00 ET | Source: Zogenix

Zogenix to Present at Two Upcoming Conferences

SAN DIEGO, Nov. 21, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
November 10, 2011 16:05 ET | Source: Zogenix

Zogenix Reports Third Quarter 2011 Financial Results

Zogenix Continued Growth of SUMAVEL DosePro Prescriptions and Reported Positive Phase 3 Efficacy Results on Zohydro Conference Call and Webcast Today, November 10th, at 4:30 p.m....